GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-03-06: Form 6-K; Period of report 2013-03-06; Description PUBLICATION OF ANNUAL REPORT 2012; Document gsk201303066k.htm.
- 2013-03-05: Form 6-K; Period of report 2013-03-05; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201303056k7.htm.
- 2013-03-05: Form 6-K; Period of report 2013-03-05; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201303056k6.htm.
- 2013-03-05: Form 6-K; Period of report 2013-03-05; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201303056k5.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2013-03-06 | 6-K | 2013-03-06 | PUBLICATION OF ANNUAL REPORT 2012 | gsk201303066k.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k7.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k6.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k5.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k4.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k3.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k2.htm |
| 2013-03-05 | 6-K | 2013-03-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201303056k1.htm |
| 2013-03-04 | 6-K | 2013-03-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201303046k3.htm |
| 2013-03-04 | 6-K | 2013-03-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201303046k1.htm |
| 2013-03-04 | 6-K | 2013-03-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201303046k4.htm |
| 2013-03-04 | 6-K | 2013-03-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201303046k2.htm |
| 2013-03-04 | 6-K | 2013-03-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201303046k.htm |
| 2013-03-01 | 6-K | 2013-03-01 | TOTAL VOTING RIGHTS | gsk201303016k.htm |
| 2013-02-25 | 6-K | 2013-02-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201302256k.htm |
| 2013-02-19 | 6-K | 2013-02-19 | DIRECTOR/PDMR SHAREHOLDING | gsk201302196k.htm |
| 2013-02-19 | 6-K | 2013-02-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201302186k.htm |
| 2013-02-15 | 6-K | 2013-02-15 | DOLUTEGRAVIR GRANTED FDA PRIORITY REVIEW | gsk201302156k.htm |
| 2013-02-12 | 6-K | 2013-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201302126k1.htm |
| 2013-02-12 | 6-K | 2013-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201302126k.htm |
| 2013-02-08 | 6-K/A | 2013-02-08 | REPLACEMENT DIRECTOR/PDMR SHAREHOLDING | gsk201302086ka.htm |
| 2013-02-07 | 6-K | 2013-02-07 | EU SUBMISSION FOR BRAF/MEK COMBINATION THERAPY | gsk201302076k.htm |
| 2013-02-06 | 6-K | 2013-02-06 | FINAL RESULTS | gsk201302066k2.htm |
| 2013-02-06 | 6-K | 2013-02-06 | GSK APPLIES IAS19R WITH EFFECT FROM 1 JANUARY 2013 | gsk201302066k.htm |
| 2013-02-05 | 6-K | 2013-02-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201302056k1.htm |
| 2013-02-05 | 6-K | 2013-02-05 | GSK INCREASES STAKE IN ITS INDIAN CONSUMER CO. | gsk201302056k.htm |
| 2013-02-01 | 6-K | 2013-02-01 | TOTAL VOTING RIGHTS | gsk201302016k.htm |
| 2013-01-31 | 6-K | 2013-01-31 | DIRECTOR/PDMR SHAREHOLDING | gsk201301316k.htm |
| 2013-01-24 | 6-K | 2013-01-24 | DIRECTORATE CHANGE | gsk201301246k.htm |
| 2013-01-22 | 6-K | 2013-01-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201301216k.htm |
| 2013-01-14 | 6-K | 2013-01-14 | GSK SUBMITS ALBIGLUTIDE BLA TO THE US FDA | gsk201301146k.htm |
| 2013-01-11 | 6-K | 2013-01-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201301116k1.htm |
| 2013-01-11 | 6-K | 2013-01-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201301116k.htm |
| 2013-01-10 | 6-K | 2013-01-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201301106k4.htm |
| 2013-01-10 | 6-K | 2013-01-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201301106k3.htm |
| 2013-01-10 | 6-K | 2013-01-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201301106k2.htm |
| 2013-01-10 | 6-K | 2013-01-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201301106k1.htm |
| 2013-01-10 | 6-K | 2013-01-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201301106k.htm |
| 2013-01-09 | 6-K | 2013-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201301096k3.htm |
| 2013-01-09 | 6-K | 2013-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201301096k2.htm |
| 2013-01-09 | 6-K | 2013-01-09 | DIRECTOR/PDMR SHAREHOLDING | gsk201301096k1.htm |
| 2013-01-09 | 6-K | 2013-01-09 | UPDATE ON UMEC/VI (ANORO) | gsk201301096k.htm |
| 2013-01-08 | 6-K | 2013-01-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201301086k.htm |
| 2013-01-07 | 6-K | 2013-01-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201301076k3.htm |
| 2013-01-07 | 6-K | 2013-01-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201301076k1.htm |
| 2013-01-07 | 6-K | 2013-01-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201301076k2.htm |
| 2013-01-07 | 6-K | 2012-10-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201301076k.htm |
| 2013-01-04 | 6-K | 2013-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201301046k3.htm |
| 2013-01-04 | 6-K | 2013-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201301046k2.htm |
| 2013-01-04 | 6-K | 2013-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201301046k1.htm |
| 2013-01-04 | 6-K | 2013-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201301046k.htm |
| 2013-01-02 | 6-K | 2013-01-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201301026k2.htm |
| 2013-01-02 | 6-K | 2013-01-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201301026k1.htm |
| 2013-01-02 | 6-K | 2013-01-02 | TOTAL VOTING RIGHTS | gsk201301026k.htm |